Bridgeway Capital Management’s Omega Protein OME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-247,400
| Closed | -$4.12M | – | 1481 |
|
|
2017
Q3 | $4.12M | Hold |
247,400
| – | – | 0.05% | 334 |
|
|
2017
Q2 | $4.43M | Hold |
247,400
| – | – | 0.05% | 289 |
|
|
2017
Q1 | $4.96M | Sell |
247,400
-118,200
| -32% | -$2.75M | 0.06% | 273 |
|
|
2016
Q4 | $9.16M | Hold |
365,600
| – | – | 0.12% | 153 |
|
|
2016
Q3 | $8.54M | Buy |
365,600
+118,200
| +48% | +$2.78M | 0.13% | 157 |
|
|
2016
Q2 | $4.95M | Sell |
247,400
-250
| -0.1% | -$4.67K | 0.08% | 234 |
|
|
2016
Q1 | $4.2M | Sell |
247,650
-2,000
| -0.8% | -$41K | 0.07% | 271 |
|
|
2015
Q4 | $5.54M | Sell |
249,650
-78,550
| -24% | -$1.64M | 0.1% | 195 |
|
|
2015
Q3 | $5.57M | Hold |
328,200
| – | – | 0.12% | 185 |
|
|
2015
Q2 | $4.51M | Hold |
328,200
| – | – | 0.09% | 245 |
|
|
2015
Q1 | $4.49M | Buy |
328,200
+30,400
| +10% | +$351K | 0.09% | 248 |
|
|
2014
Q4 | $3.15M | Hold |
297,800
| – | – | 0.07% | 338 |
|
|
2014
Q3 | $3.72M | Hold |
297,800
| – | – | 0.09% | 246 |
|
|
2014
Q2 | $4.07M | Hold |
297,800
| – | – | 0.11% | 236 |
|
|
2014
Q1 | $3.59M | Buy |
297,800
+20,000
| +7% | +$229K | 0.1% | 247 |
|
|
2013
Q4 | $3.41M | Buy |
277,800
+34,900
| +14% | +$409K | 0.1% | 240 |
|
|
2013
Q3 | $2.47M | Hold |
242,900
| – | – | 0.08% | 328 |
|
|
2013
Q2 | $2.18M | Buy |
+242,900
| New | +$2.45M | 0.09% | 306 |
|
Bridgeway Capital Management's OME Position: Q4 2017 in Review
Bridgeway Capital Management sold out of Omega Protein (OME) in Q4 2017, closing a stake of 247,400 shares — an estimated $4.12M sold.
Bridgeway Capital Management first reported a position in OME in Q2 2013 and held it in 18 quarters. The position peaked at $9.16M in Q4 2016. 0 funds tracked by Wall St. Rank hold OME as of Q4 2017.
- Bridgeway Capital Management reported no remaining Omega Protein position as of Q4 2017 after selling out during the quarter.
- Bridgeway Capital Management sold 247,400 Omega Protein shares in Q4 2017, an estimated $4.12M.
- Bridgeway Capital Management first reported a position in Omega Protein in Q2 2013 and held it in 18 quarters.
- Bridgeway Capital Management's Omega Protein position peaked at $9.16M in Q4 2016.
- 0 funds tracked by Wall St. Rank held Omega Protein as of Q4 2017.
Based on Bridgeway Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.